# Construction of an In Vitro Blood–Brain Barrier Micro-Organoid Model Using Decellularized Squid Mantle Scaffold Film

**Authors:** Haoyu Sun, Xiaozhen Diao, Jiali Feng, Huiying Wang, Jeevithan Elango, Wenhui Wu

PMC · DOI: 10.3390/jfb17020106 · Journal of Functional Biomaterials · 2026-02-23

## TL;DR

Researchers created a new in vitro model of the blood-brain barrier using a squid mantle scaffold to better study neurological diseases and drug permeability.

## Contribution

A novel BBB micro-organoid model using decellularized squid mantle scaffold films for a more authentic NVU microenvironment.

## Key findings

- The DSMS film supported the growth of endothelial and astrocyte cells, forming a BBB-like structure.
- The model showed functional barrier properties with high TEER and low permeability to macromolecules.
- LRP1 expression was used to assess model integrity and response to thrombotic conditions.

## Abstract

Although blood–brain barrier (BBB) models are of great value in investigating neurological diseases, the structural complexity and intricate function based on cell–cell interactions of the BBB bring various limitations to the applications of existing models. In this study, a novel BBB micro-organoid model was established by culturing neurovascular unit (NVU) cells on a decellularized squid mantle scaffold (DSMS) film to reconstitute a more authentic and reliable NVU microenvironment for in vitro research. The DSMS applied was obtained from squid mantle scaffolds via decellularization, followed by defatting, and showed good biocompatibility with no cytotoxicity. The DSMS film was finally prepared by lyophilization. The lyophilized film exhibited a void ratio and pore size suitable for the adhesion and growth of endothelial cells (hCMEC/D3) and astrocytes (hACs), which led to the formation of a BBB-like spatial structure. The BBB micro-organoid model exhibited functional barrier properties, including an effective transendothelial electrical resistance (TEER) of approximately 230 Ω/cm2, restricted permeability to macromolecules—with apparent permeability coefficients (Papp) of 6.3 × 10−7 cm/s for 10 kDa and 2.7 × 10−7 cm/s for 70 kDa FITC–dextran—and expression of tight junctional complex (TJC) proteins such as vascular endothelial cadherin (VE-cad) and Zonula Occludens-1 (ZO-1). Furthermore, low-density lipoprotein receptor-related protein 1 (LRP1), a key receptor stably expressed in these two NVU cell types, was utilized as a critical indicator to assess the integrity of the BBB micro-organ model and its responsiveness to pathophysiological stimuli, particularly under thrombotic conditions. This study not only validates the feasibility of constructing a functionally competent BBB micro-organ model using DSMS films integrated with NVU cells but also provides a promising in vitro platform for subsequent studies on the BBB-related pathological mechanisms and the evaluation of drug permeability across the BBB.

## Linked entities

- **Proteins:** Cdh5 (cadherin 5), TJP1 (tight junction protein 1), LRP1 (LDL receptor related protein 1)

## Full-text entities

- **Genes:** FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, LRP1 (LDL receptor related protein 1) [NCBI Gene 4035] {aka A2MR, APOER, APR, CD91, DDH3, IGFBP-3R}, CLDN5 (claudin 5) [NCBI Gene 7122] {aka AWAL, BEC1, CPETRL1, TMDVCF, TMVCF}, LRPAP1 (LDL receptor related protein associated protein 1) [NCBI Gene 4043] {aka A2MRAP, A2RAP, HBP44, MYP23, RAP, alpha-2-MRAP}, Tjp1 (tight junction protein 1) [NCBI Gene 292994] {aka ZO-1}, CDH5 (cadherin 5) [NCBI Gene 1003] {aka 7B4, CD144}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, PLAT (plasminogen activator, tissue type) [NCBI Gene 5327] {aka T-PA, TPA}
- **Diseases:** neuroinflammation (MESH:D000090862), BBB (MESH:C536830), inflammation (MESH:D007249), injury to (MESH:D014947), neurological diseases (MESH:D020271), NVU (MESH:D013901), cardiovascular and cerebrovascular diseases (MESH:D002318), coagulation (MESH:D001778), Cytotoxicity (MESH:D064420), thrombosis (MESH:D013927), brain diseases (MESH:D001927)
- **Chemicals:** Triton X-100 (MESH:D017830), gold (MESH:D006046), Calcein AM (MESH:C085925), oxygen (MESH:D010100), PI (MESH:D010716), phosphate (MESH:D010710), acid (MESH:D000143), SDS (MESH:D012967), acetic acid (MESH:D019342), silver chloride (MESH:C037548), silver (MESH:D012834), FITC-dextran (MESH:C015219), ethanol (MESH:D000431), palladium (MESH:D010165), water (MESH:D014867), carbohydrate (MESH:D002241), dextrans (MESH:D003911), AM 1801 (-), glycosaminoglycan (MESH:D006025), 60Co (MESH:C000615395), glutaraldehyde (MESH:D005976), 4',6-diamidino-2-phenylindole (MESH:C007293), CO2 (MESH:D002245), AM (MESH:D000576), Calcein (MESH:C007740), paraformaldehyde (MESH:C003043)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Bos taurus (bovine, species) [taxon 9913]
- **Cell lines:** SVG p12 — Homo sapiens (Human), Transformed cell line (CVCL_3797), hCMEC — Homo sapiens (Human), Transformed cell line (CVCL_U985)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941411/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941411/full.md

## References

82 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941411/full.md

---
Source: https://tomesphere.com/paper/PMC12941411